Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'PRENATAL SCREENING' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 140 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Alderson, P; Aro, AR; Dragonas, T; Ettorre, E; Hemminki, E; Jalinoja, P; Santalahti, P; Tymstra, T
      Prenatal screening and genetics

      EUROPEAN JOURNAL OF PUBLIC HEALTH
    2. Garne, E; Berghold, A; Johnson, Z; Stoll, C
      Different policies on prenatal ultrasound screening programmes and inducedabortions explain regional variations in infant mortality with congenital malformations

      FETAL DIAGNOSIS AND THERAPY
    3. Alderson, P
      Prenatal screening, ethics and Down's syndrome: A literature review

      NURSING ETHICS
    4. Garne, E; Stoll, C; Clementi, M
      Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries

      ULTRASOUND IN OBSTETRICS & GYNECOLOGY
    5. Toth, A; Tardy, EP; Hajdu, K; Batorfi, J; Doszpod, J; Egyed, J; Gati, I
      Fluorescence in situ hybridization of chorionic interphase cells for prenatal screening of Down syndrome

      EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY
    6. Alderson, P
      Down's syndrome: cost, quality and value of life

      SOCIAL SCIENCE & MEDICINE
    7. Yamamoto, R; Azuma, M; Hoshi, N; Kishida, T; Satomura, S; Fujimoto, S
      Lens culinaris agglutinin-reactive alpha-fetoprotein, an alternative variant to alpha-fetoprotein in prenatal screening for Down's syndrome

      HUMAN REPRODUCTION
    8. Spencer, K
      Screening for trisomy 21 in twin pregnancies in the first trimester: does chorionicity impact on maternal serum free beta-hCG or PAPP-A levels?

      PRENATAL DIAGNOSIS
    9. Spencer, K; Liao, AW; Ong, CYT; Geerts, L; Nicolaides, KH
      First trimester maternal serum placenta growth factor (PIGF) concentrations in pregnancies with fetal trisomy 21 or trisomy 18

      PRENATAL DIAGNOSIS
    10. Wojdemann, KR; Larsen, SO; Shalmi, A; Sundberg, K; Christiansen, M; Tabor, A
      First trimester screening for Down syndrome and assisted reproduction: no basis for concern

      PRENATAL DIAGNOSIS
    11. Spencer, K; Liao, AW; Ong, CYT; Flack, NJ; Nicolaides, KH
      Maternal serum activin A and inhibin A in trisomy 18 pregnancies at 10-14 weeks

      PRENATAL DIAGNOSIS
    12. Spencer, K; Liao, AW; Ong, CYT; Geerts, L; Nicolaides, KH
      Maternal serum levels of dimeric inhibin A in pregnancies affected by trisomy 21 in the first trimester

      PRENATAL DIAGNOSIS
    13. Spencer, K
      Between pregnancy biological variability of first trimester markers of Down syndrome: implications for screening in subsequent pregnancies

      PRENATAL DIAGNOSIS
    14. Spencer, K; Liao, AW; Skentou, H; Ong, CYT; Nicolaides, KH
      Maternal serum levels of total activin-A in first-trimester trisomy 21 pregnancies

      PRENATAL DIAGNOSIS
    15. Halliday, JL; Warren, R; McDonald, G; Rice, PL; Bell, RJ; Watson, LF
      Prenatal diagnosis for women aged 37 years and over: to have or not to have

      PRENATAL DIAGNOSIS
    16. Jallinoja, P
      Genetic screening in maternity care: preventive aims and voluntary choices

      SOCIOLOGY OF HEALTH & ILLNESS
    17. Bryant, LD; Green, JM; Hewison, J
      Prenatal screening for Down's syndrome: some psychosocial implications of a 'screening for all' policy

      PUBLIC HEALTH
    18. Rausch, DN; Lambert-Messerlian, GM; Canick, JA
      Participation in maternal serum screening following screen positive results in a previous pregnancy

      JOURNAL OF MEDICAL SCREENING
    19. Babl, FE; Ram, S; Barnett, ED; Rhein, L; Carr, E; Cooper, ER
      Neonatal gonococcal arthritis after negative prenatal screening and despite conjunctival prophylaxis

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    20. Foulon, W; Naessens, A; Ho-Yen, D
      Prevention of congenital toxoplasmosis

      JOURNAL OF PERINATAL MEDICINE
    21. Marteau, TM; Saidi, G; Goodburn, S; Lawton, J; Michie, S; Bobrow, M
      Numbers or words? A randomized controlled trial of presenting screen negative results to pregnant women

      PRENATAL DIAGNOSIS
    22. Spencer, K; Ong, CYT; Liao, AWJ; Papademetriou, D; Nicolaides, KH
      The influence of fetal sex in screening for trisomy 21 by fetal nuchal translucency, maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation

      PRENATAL DIAGNOSIS
    23. Spencer, K; Ong, CYT; Liao, AWJ; Nicolaides, KH
      The influence of ethnic origin on first trimester biochemical markers of chromosomal abnormalities

      PRENATAL DIAGNOSIS
    24. Spencer, K; Liao, AWJ; Skentou, H; Cicero, S; Nicolaides, KH
      Screening for triploidy by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation

      PRENATAL DIAGNOSIS
    25. Spencer, K; Ong, C; Skentou, H; Liao, AW; Nicolaides, KH
      Screening for trisomy 13 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation

      PRENATAL DIAGNOSIS
    26. Spencer, K; Ong, CYT; Liao, AWJ; Nicolaides, KH
      The influence of parity and gravidity on first trimester markers of chromosomal abnormality

      PRENATAL DIAGNOSIS
    27. Quinlan, LCDRJD; Hill, DA; Maxwell, BD; Boone, S; Hoover, F; Lense, JJ
      The necessity of both anorectal and vaginal cultures for group B streptococcus screening during pregnancy

      JOURNAL OF FAMILY PRACTICE
    28. Griemberg, G; Ravelli, MR; Etcheves, PD; Orfus, G; Pizzimenti, MC
      Syphilis and pregnancy. Prenatal control, seroprevalence and false biological positives.

      MEDICINA-BUENOS AIRES
    29. O'Connell, MP; Holding, S; Morgan, RJ; Lindow, SW
      Biochemical screening for Down syndrome: patients' perception of risk

      INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
    30. Stoll, C; Dott, B; Alembik, Y; Roth, MP
      Evaluation of prenatal diagnosis of cleft lip/palate by foetal ultrasonographic examination

      ANNALES DE GENETIQUE
    31. Santalahti, P; Hemminki, E; Aro, AR; Helenius, H; Ryynanen, M
      Participation in prenatal screening tests and intentions concerning selective termination in Finnish maternity care

      FETAL DIAGNOSIS AND THERAPY
    32. Goshen, R; Gonik, B; Ariel, I; Weiss, Y; de-Groot, N; Hochberg, A
      High levels of maternal serum human chorionic gonadotropin in Down syndrome pregnancies: The possible role of a transcription factor on chromosome 21

      FETAL DIAGNOSIS AND THERAPY
    33. Haddow, JE; Bradley, LA; Palomaki, GE; Doherty, RA
      Issues in implementing prenatal screening for cystic fibrosis: results of a working conference

      JOURNAL OF MEDICAL SCREENING
    34. Spencer, K; Souter, V; Tul, N; Snijders, R; Nicolaides, KH
      A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A

      ULTRASOUND IN OBSTETRICS & GYNECOLOGY
    35. Demsey, SA
      Carrier screening for cystic fibrosis: A perinatal perspective

      JOURNAL OF PERINATAL & NEONATAL NURSING
    36. Markens, S; Browner, CH; Press, N
      'Because of the risks': how US pregnant women account for refusing prenatal screening

      SOCIAL SCIENCE & MEDICINE
    37. Hsu, JJ; Spencer, K; Hung, TH; Hsieh, TT; Soong, YK
      Second-trimester maternal urine human chorionic gonadotrophin beta-core fragment concentrations in Asian pregnancies with fetal chromosomal abnormalities

      HUMAN REPRODUCTION
    38. De Biasio, P; Siccardi, M; Volpe, G; Famularo, L; Santi, F; Canini, S
      First-trimester screening for Down syndrome using nuchal translucency measurement with free beta-hCG and PAPP-A between 10 and 13 weeks of pregnancy - the combined test

      PRENATAL DIAGNOSIS
    39. Spencer, K; Crossley, JA; Green, K; Worthington, DJ; Brownbill, K; Aitken, DA
      Second trimester levels of pregnancy associated plasma protein-A in cases of trisomy 18

      PRENATAL DIAGNOSIS
    40. Tul, N; Spencer, K; Noble, P; Chan, C; Nicolaides, K
      Screening for trisomy 18 by fetal nuchal translucency and maternal serum free beta-hCG and PAPP-A at 10-14 weeks of gestation

      PRENATAL DIAGNOSIS
    41. Ognibene, A; Ciuti, R; Tozzi, P; Messeri, G
      Maternal serum superoxide dismutase (SOD): A possible marker for screeningDown syndrome affected pregnancies

      PRENATAL DIAGNOSIS
    42. Christiansen, M; Oxvig, C; Wagner, JM; Qin, QP; Nguyen, TH; Overgaard, MT; Larsen, SO; Sottrup-Jensen, L; Gleich, GJ; Norgaard-Pedersen, B
      The preform of eosinophil major basic protein: A new maternal serum markerfor Down syndrome

      PRENATAL DIAGNOSIS
    43. Wenstrom, KD; Descartes, M; Franklin, J; Cliver, SP
      A five-year experience with fragile X screening of high-risk gravid women

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    44. Hanley, WB; Platt, LD; Bachman, RP; Buist, N; Geraghty, MT; Isaacs, J; O'Flynn, ME; Rhead, WJ; Seidlitz, G; Tishler, B
      Undiagnosed maternal phenylketonuria: The need for prenatal selective screening or case finding

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    45. Hemminki, E; Santalahti, P; Toiviainen, H
      Impact of prenatal screening on maternity services - Finnish physicians' opinions

      ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
    46. SANTALAHTI P; HEMMINKI E
      USE OF PRENATAL SCREENING-TESTS IN FINLAND

      European journal of public health
    47. GUARIGLIA L; ROSATI P
      TRANSVAGINAL SONOGRAPHIC FETAL BIPARIETAL DIAMETER KIDNEY LENGTH RATIO IN EARLY-PREGNANCY AS A SCREENING TOOL FOR RENAL MALFORMATIONS

      Fetal diagnosis and therapy
    48. Hsu, JJ; Hung, TH; Liou, JD; Hsieh, TT; Soong, YK
      Elevated second-trimester maternal urine free beta-human chorionic gonadotropin levels in Asian pregnancies with fetal chromosomal abnormalities

      FETAL DIAGNOSIS AND THERAPY
    49. Feldman, B; Dvorin, E; Phillips, T; Kramer, RL; Johnson, MP; Evans, MI
      2nd-trimester maternal serum marker results are not altered by delayed analysis

      FETAL DIAGNOSIS AND THERAPY
    50. HADDOW JE; PALOMAKI GE; KNIGHT GJ; FOSTER DL; NEVEUX LM
      2ND-TRIMESTER SCREENING FOR DOWNS-SYNDROME USING MATERNAL SERUM DIMERIC INHIBIN-A

      Journal of medical screening
    51. Doren, M; Rehder, H; Holzgreve, W
      Prenatal diagnosis and obstetric management of Larsen's syndrome in a patient with an unrecognized family history of the disease

      GYNECOLOGIC AND OBSTETRIC INVESTIGATION
    52. SANTALAHTI P; HEMMINKI E; LATIKKA AM; RYYNANEN MU
      WOMENS DECISION-MAKING IN PRENATAL SCREENING

      Social science & medicine
    53. HAFNER E; SCHOLLER J; SCHUCHTER K; STERNISTE W; PHILIPP K
      DETECTION OF FETAL CONGENITAL HEART-DISEASE IN A LOW-RISK POPULATION

      Prenatal diagnosis
    54. WATT HC; WALD NJ
      ALTERNATIVE METHODS OF MATERNAL WEIGHT ADJUSTMENT IN MATERNAL SERUM SCREENING FOR DOWN-SYNDROME AND NEURAL-TUBE DEFECTS

      Prenatal diagnosis
    55. WATT HC; WALD NJ; HUTTLY WJ
      THE PATTERN OF MATERNAL SERUM INHIBIN-A CONCENTRATIONS IN THE 2ND-TRIMESTER OF PREGNANCY

      Prenatal diagnosis
    56. LARSEN SO; CHRISTIANSEN M; NORGAARDPEDERSEN B
      INCLUSION OF SERUM MARKER MEASUREMENTS FROM A PREVIOUS PREGNANCY IMPROVES DOWN-SYNDROME SCREENING PERFORMANCE

      Prenatal diagnosis
    57. SPENCER K
      THE INFLUENCE OF SMOKING ON MATERNAL SERUM AFP AND FREE BETA-HCG LEVELS AND THE IMPACT ON SCREENING FOR DOWN-SYNDROME

      Prenatal diagnosis
    58. KNIGHT GJ; PALOMAKI GE; NEVEUX LM; FODOR KK; HADDOW JE
      HCG AND THE FREE BETA-SUBUNIT AS SCREENING-TESTS FOR DOWN-SYNDROME

      Prenatal diagnosis
    59. SCHUCHTER K; WALD N; HACKSHAW AK; HAFNER E; LIEBHART E
      THE DISTRIBUTION OF NUCHAL TRANSLUCENCY AT 10-13 WEEKS OF PREGNANCY

      Prenatal diagnosis
    60. WALD NJ; WATT HC; HADDOW JE; KNIGHT GJ
      SCREENING FOR DOWN-SYNDROME AT 14 WEEKS OF PREGNANCY

      Prenatal diagnosis
    61. SANTALAHTI P; ARO AR; HEMMINKI E; HELENIUS H; RYYNANEN M
      ON WHAT GROUNDS DO WOMEN PARTICIPATE IN PRENATAL SCREENING

      Prenatal diagnosis
    62. DANTONA D; WALLACE EM; SHEARING C; ASHBY JP; GROOME NP
      INHIBIN-A AND PRO-ALPHA-C INHIBIN IN DOWN-SYNDROME AND NORMAL PREGNANCIES

      Prenatal diagnosis
    63. Beazoglou, T; Heffley, D; Kyriopoulos, J; Vintzileos, A; Benn, P
      Economic evaluation of prenatal screening for Down syndrome in the USA

      PRENATAL DIAGNOSIS
    64. Mawn, B
      Integrating women's perspectives on prenatal human immunodeficiency virus screening: Toward a socially just policy

      RESEARCH IN NURSING & HEALTH
    65. WALLACE EM; CROSSLEY JA; RITOE SC; AITKEN DA; SPENCER K; GROOME NP
      EVOLUTION OF AN INHIBIN-A ELISA METHOD - IMPLICATIONS FOR DOWNS-SYNDROME SCREENING

      Annals of clinical biochemistry
    66. ORLANDI F; DAMIANI G; HALLAHAN TW; KRANTZ DA; MACRI JN
      FIRST-TRIMESTER SCREENING FOR FETAL ANEUPLOIDY - BIOCHEMISTRY AND NUCHAL TRANSLUCENCY

      Ultrasound in obstetrics & gynecology
    67. HALL S; BOBROW M; MARTEAU TM
      PARENTS ATTRIBUTIONS OF BLAME FOR THE BIRTH OF A CHILD WITH DOWN-SYNDROME - A PILOT-STUDY

      Psychology & health
    68. PRESS N; BROWNER CH
      WHY WOMEN SAY YES TO PRENATAL-DIAGNOSIS

      Social science & medicine
    69. MENNIE ME; AXWORTHY D; LISTON WA; BROCK DJH
      PRENATAL SCREENING FOR CYSTIC-FIBROSIS CARRIERS - DOES THE METHOD OF TESTING AFFECT THE LONGER-TERM UNDERSTANDING AND REPRODUCTIVE-BEHAVIOROF WOMEN

      Prenatal diagnosis
    70. SUZUMORI K; TANEMURA M; MURAKAMI I; OKADA S; NATORI M; TANAKA M; TAKAGI T; SATO A
      A RETROSPECTIVE EVALUATION OF MATERNAL SERUM SCREENING FOR THE DETECTION OF FETAL ANEUPLOIDY

      Prenatal diagnosis
    71. SPENCER K; MULLER F; AITKEN DA
      AMNIOTIC-FLUID AND MATERNAL SERUM LEVELS OF CA125 IN PREGNANCIES AFFECTED BY DOWN-SYNDROME - A REEVALUATION OF THE ROLE OF CA125 IN DOWN-SYNDROME SCREENING

      Prenatal diagnosis
    72. DORTICOSBALEA A; MARTINRUIZ M; HECHEVARRIAFERNANDEZ P; ROBAINACASTELLANOS MS; RODRIGUEZBLANCO M; MORASBRACERO F; IBARRA HG
      REPRODUCTIVE-BEHAVIOR OF COUPLES AT RISK FOR SICKLE-CELL DISEASE IN CUBA - A FOLLOW-UP-STUDY

      Prenatal diagnosis
    73. HUANG T; WATT HC; WALD NJ
      THE EFFECT OF DIFFERENCES IN THE DISTRIBUTION OF MATERNAL AGE IN ENGLAND AND WALES ON THE PERFORMANCE OF PRENATAL SCREENING FOR DOWNS-SYNDROME

      Prenatal diagnosis
    74. SPENCER K; NOBLE P; SNIJDERS RJM; NICOLAIDES KH
      FIRST-TRIMESTER URINE FREE BETA-HCG, BETA-CORE, AND TOTAL ESTRIOL IN PREGNANCIES AFFECTED BY DOWNS-SYNDROME - IMPLICATIONS FOR FIRST-TRIMESTER SCREENING WITH NUCHAL TRANSLUCENCY AND SERUM-FREE BETA-HCG

      Prenatal diagnosis
    75. SPENCER K
      BETWEEN-PREGNANCY BIOLOGICAL VARIABILITY OF MATERNAL SERUM ALPHA-FETOPROTEIN AND FREE BETA-HCG - IMPLICATIONS FOR DOWN-SYNDROME SCREENING IN SUBSEQUENT PREGNANCIES

      Prenatal diagnosis
    76. HAFNER E; STERNISTE W; SCHOLLER J; SCHUCHTER K; PHILIPP K
      PRENATAL-DIAGNOSIS OF FACIAL MALFORMATIONS

      Prenatal diagnosis
    77. LEVENKRON JC; LOADER S; ROWLEY PT
      CARRIER SCREENING FOR CYSTIC-FIBROSIS - TEST ACCEPTANCE AND ONE-YEAR FOLLOW-UP

      American journal of medical genetics
    78. WRIGHT D; STANDER J; NICOLAIDES K
      NONPARAMETRIC DENSITY-ESTIMATION AND DISCRIMINATION FROM IMAGES OF SHAPES

      Applied Statistics
    79. FAIRGRIEVE S; MAGNAY D; WHITE I; BURN J
      MATERNAL SERUM SCREENING FOR DOWNS-SYNDROME - A SURVEY OF MIDWIVES VIEWS

      Public health
    80. ESEN UI; OLAJIDE F
      EXPECTATIONS AND FEARS OF WOMEN REGARDING 2 METHODS OF PRENATAL SCREENING

      International journal of gynaecology and obstetrics
    81. BRYANT DR; ZADOR I; LANDWEHR JB; WOLFE HM
      LIMITED CLINICAL UTILITY OF MIDTRIMESTER FETAL MORPHOMETRIC PERCENTILE RANKINGS IN SCREENING FOR BIRTH-WEIGHT ABNORMALITIES

      American journal of obstetrics and gynecology
    82. PALOMAKI GE; KNIGHT GJ; MCCARTHY JE; HADDOW JE; DONHOWE JM
      MATERNAL SERUM SCREENING FOR DOWN-SYNDROME IN THE UNITED-STATES - A 1995 SURVEY

      American journal of obstetrics and gynecology
    83. BRADLEY LA; CANICK JA; PALOMAKI GE; HADDOW JE
      UNDETECTABLE MATERNAL SERUM UNCONJUGATED ESTRIOL LEVELS IN THE 2ND TRIMESTER - RISK OF PERINATAL COMPLICATIONS ASSOCIATED WITH PLACENTAL SULFATASE DEFICIENCY

      American journal of obstetrics and gynecology
    84. DOHERTY RA; BRADLEY LA; HADDOW JE
      PRENATAL SCREENING FOR CYSTIC-FIBROSIS - AN UPDATED PERSPECTIVE

      American journal of obstetrics and gynecology
    85. TAFAS T; CUCKLE HS; NASR S; KRIVCHENIA EL; RESVANI E; EVANS MI
      AN AUTOMATED IMAGE-ANALYSIS METHOD FOR THE MEASUREMENT OF NEUTROPHIL ALKALINE-PHOSPHATASE IN THE PRENATAL SCREENING OF DOWN-SYNDROME

      Fetal diagnosis and therapy
    86. VESCE F; FARINA A; JORIZZO G; TARABBIA C; CALABRESE O; PELIZZOLA D; GIOVANNINI G; PIFFANELLI A
      RAISED LEVEL OF AMNIOTIC ENDOTHELIN IN PREGNANCIES WITH FETAL ANEUPLOIDY

      Fetal diagnosis and therapy
    87. BROWNER CH; PRELORAN M; PRESS NA
      THE EFFECTS OF ETHNICITY, EDUCATION AND AN INFORMATIONAL VIDEO ON PREGNANT WOMENS KNOWLEDGE AND DECISIONS ABOUT A PRENATAL DIAGNOSTIC SCREENING-TEST

      Patient education and counseling
    88. AYME S
      CONTRIBUTION OF REGISTRIES TO THE DECISIO N-PROCESS IN PUBLIC-HEALTH - THE EXAMPLE OF TRISOMY-21

      Revue d'epidemiologie et de sante publique
    89. BUFFOLANO W; GRAPPONE L; DESILVA C; PALUMBO F; CICCIMARRA F
      CONGENITAL TOXOPLASMOSIS - NEEDING FOR PE DIATRIC GUIDELINES AND REFERRING CENTERS

      Rivista italiana di pediatria
    90. BUFFOLANO W; DALLACASA P; RANNO O; BOSI I; FRATTA D; VALENTINI P
      MULTICENTER STUDY ON DIAGNOSIS AND FOLLOW -UP OF CHILDREN BORN TO MOTHER IDENTIFIED AS INFECTED WITH TOXOPLASMA DURING PREGNANCY

      Rivista italiana di pediatria
    91. THORNTON JG; VANDENBORNE MPJ; DEBRUIJN AJE
      RISK COMMUNICATION - THE PATIENTS VIEW

      Early human development
    92. PALOMAKI GE
      DOWNS-SYNDROME EPIDEMIOLOGY AND RISK-ESTIMATION

      Early human development
    93. MULLER F; DOMMERGUES M; BUSSIERES L; AEGERTER P; LEFIBLEC B; UZAN S; OURY JF; COLAU JC; DUMEZ Y
      PRENATAL SCREENING FOR DOWN-SYNDROME - SHOULD FIRST TRIMESTER ULTRASOUND REPLACE MATERNAL SERUM SCREENING

      Early human development
    94. KNIGHT GJ
      QUALITY ASSESSMENT OF A PRENATAL SCREENING-PROGRAM

      Early human development
    95. GRAY JC; DUNSTAN FDJ; NIX ABJ
      DETECTION RATES AND FALSE-POSITIVE RATES FOR DOWN-SYNDROME SCREENING - HOW PRECISELY CAN THEY BE ESTIMATED

      Early human development
    96. MULLER F; BUSSIERES L
      MATERNAL SERUM MARKERS FOR FETAL TRISOMY-21 SCREENING

      European journal of obstetrics, gynecology, and reproductive biology
    97. WATT HC; WALD NJ; SMITH D; KENNARD A; DENSEM J
      EFFECT OF ALLOWING FOR ETHNIC-GROUP IN PRENATAL SCREENING FOR DOWNS-SYNDROME

      Prenatal diagnosis
    98. WALD NJ; WATT HC
      SERUM MARKERS FOR DOWNS-SYNDROME IN RELATION TO NUMBER OF PREVIOUS BIRTHS AND MATERNAL AGE

      Prenatal diagnosis
    99. SPENCER K; AITKEN DA; MACRI JN; BUCHANAN PD
      URINE FREE BETA-HCG AND BETA-CORE IN PREGNANCIES AFFECTED BY DOWNS-SYNDROME

      Prenatal diagnosis
    100. DOHERTY RA; PALOMAKI GE; KLOZA EM; ERICKSON JL; HADDOW JE
      COUPLE-BASED PRENATAL SCREENING FOR CYSTIC-FIBROSIS IN PRIMARY-CARE SETTINGS

      Prenatal diagnosis


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 20:33:18